PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE.
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974584.83737.e4 |
_version_ | 1797281599958548480 |
---|---|
author | Idanna Innocenti Antonio Mosca Annamaria Tomasso Andrea Galitzia Lydia Scarfò Eugenio Galli Roberta Laureana Giulia Benintende Veronica Mattiello Francesca Morelli Sabrina Chiriu Maria Ilaria Del Principe Giulia Zamprogna Massimo Gentile Nicole Fabbri Francesco Autore Paolo Sportoletti Alberto Fresa Gioacchino Catania Marta Coscia Alessandra Tedeschi Alessandro Sanna Marzia Varettoni Paolo Ghia Roberta Murru Luca Laurenti |
author_facet | Idanna Innocenti Antonio Mosca Annamaria Tomasso Andrea Galitzia Lydia Scarfò Eugenio Galli Roberta Laureana Giulia Benintende Veronica Mattiello Francesca Morelli Sabrina Chiriu Maria Ilaria Del Principe Giulia Zamprogna Massimo Gentile Nicole Fabbri Francesco Autore Paolo Sportoletti Alberto Fresa Gioacchino Catania Marta Coscia Alessandra Tedeschi Alessandro Sanna Marzia Varettoni Paolo Ghia Roberta Murru Luca Laurenti |
author_sort | Idanna Innocenti |
collection | DOAJ |
first_indexed | 2024-03-07T16:59:46Z |
format | Article |
id | doaj.art-2e6cd939c384487a942999748beac5be |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:59:46Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-2e6cd939c384487a942999748beac5be2024-03-03T03:24:54ZengWileyHemaSphere2572-92412023-08-017e83737e410.1097/01.HS9.0000974584.83737.e4202308003-01820PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE.Idanna Innocenti0Antonio Mosca1Annamaria Tomasso2Andrea Galitzia3Lydia Scarfò4Eugenio Galli5Roberta Laureana6Giulia Benintende7Veronica Mattiello8Francesca Morelli9Sabrina Chiriu10Maria Ilaria Del Principe11Giulia Zamprogna12Massimo Gentile13Nicole Fabbri14Francesco Autore15Paolo Sportoletti16Alberto Fresa17Gioacchino Catania18Marta Coscia19Alessandra Tedeschi20Alessandro Sanna21Marzia Varettoni22Paolo Ghia23Roberta Murru24Luca Laurenti251 Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy2 Università Cattolica del Sacro Cuore, Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Rome, Italy2 Università Cattolica del Sacro Cuore, Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Rome, Italy3 University of Cagliari, Department of Medical Sciences and Public Health, Monserrato, Italy4 Università Vita Salute and IRCSS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy1 Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy5 University of Tor Vergata, Division of Haematology, Rome, Italy6 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsklinikum, Department of Medicine 5, Haematology and Oncology, Erlangen, Germany7 Fondazione IRCCS Ca’ Granda Policlinico, Hematology Unit, Milano, Italy8 University of Florence, Hematology, Firenze, Italy3 University of Cagliari, Department of Medical Sciences and Public Health, Monserrato, Italy5 University of Tor Vergata, Division of Haematology, Rome, Italy9 ASST Grande Ospedale Metropolitano Niguarda, Department of Hematology, Niguarda Cancer Center, Milano, Italy10 Cosenza Hospital, Hematology Section, Cosenza, Italy11 Università di Pavia, Dipartimento di Medicina Molecolare, Pavia, Italy1 Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy12 University of Perugia, Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, Institute of Hematology, Perugia1 Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy13 Hospital Saints (A. O. SS) Antonio e Biagio and Cesare Arrigo, Division of Hematology,, Alessandria, Italy14 A.O.U. Città della Salute e della Scienza di Torino, Division of Haematology, Torino, Italy9 ASST Grande Ospedale Metropolitano Niguarda, Department of Hematology, Niguarda Cancer Center, Milano, Italy16 AOU Careggi, Hematology, Department of Oncology, Firenze, Italy17 Fondazione IRCCS Policlinico San Matteo, Division of Hematology, Pavia, Italy4 Università Vita Salute and IRCSS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy18 Ospedale Oncologico Armando Businco, ARNAS G. Brotzu, Hematology and Transplant Centre, Cagliari, Italy1 Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italyhttp://journals.lww.com/10.1097/01.HS9.0000974584.83737.e4 |
spellingShingle | Idanna Innocenti Antonio Mosca Annamaria Tomasso Andrea Galitzia Lydia Scarfò Eugenio Galli Roberta Laureana Giulia Benintende Veronica Mattiello Francesca Morelli Sabrina Chiriu Maria Ilaria Del Principe Giulia Zamprogna Massimo Gentile Nicole Fabbri Francesco Autore Paolo Sportoletti Alberto Fresa Gioacchino Catania Marta Coscia Alessandra Tedeschi Alessandro Sanna Marzia Varettoni Paolo Ghia Roberta Murru Luca Laurenti PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. HemaSphere |
title | PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. |
title_full | PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. |
title_fullStr | PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. |
title_full_unstemmed | PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. |
title_short | PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE. |
title_sort | pb1942 partial response with lymphocytosis pr l is not applicable for acalabrutinib an italian multicenter experience of real life |
url | http://journals.lww.com/10.1097/01.HS9.0000974584.83737.e4 |
work_keys_str_mv | AT idannainnocenti pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT antoniomosca pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT annamariatomasso pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT andreagalitzia pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT lydiascarfo pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT eugeniogalli pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT robertalaureana pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT giuliabenintende pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT veronicamattiello pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT francescamorelli pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT sabrinachiriu pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT mariailariadelprincipe pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT giuliazamprogna pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT massimogentile pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT nicolefabbri pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT francescoautore pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT paolosportoletti pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT albertofresa pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT gioacchinocatania pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT martacoscia pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT alessandratedeschi pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT alessandrosanna pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT marziavarettoni pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT paologhia pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT robertamurru pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife AT lucalaurenti pb1942partialresponsewithlymphocytosisprlisnotapplicableforacalabrutinibanitalianmulticenterexperienceofreallife |